Clarity Solutions, Inc.

USA

RELATED CONTENT

Master Supply Agreement encompasses clinical development and commercial supply for Clarity’s Cu-67-based candidates to treat neuroblastoma, breast and prostate cancers, among others
News | Radiopharmaceuticals and Tracers

NorthStar Medical Radioisotopes Enters U.S. Supply Agreement for ...

June 22, 2021 — NorthStar Medical Radioisotopes, LLC, a global innovator in the development, production and ...

Time June 22, 2021
Read more
Clarity Pharmaceuticals, a radiopharmaceutical company focused on the treatment of serious disease, and ImaginAb, Inc., a company that harnesses the specificity of monoclonal antibodies, have entered into a collaboration agreement to develop new targeted theranostic (diagnostic and therapy) products for a broad range of cancer types.
News | Radiation Oncology

Clarity Pharmaceuticals and ImaginAb Collaborate on New Cancer Targets

July 29, 2020 — Clarity Pharmaceuticals, a radiopharmaceutical company focused on the treatment of serious disease, and ...

Time July 29, 2020
Read more
Technology

Web-Based Image Delivery Tool with Diagnostic Viewer

The standard version of PETLinQ is a Web-based tool for delivering PET images and reports to the referring physician’s ...

Time June 27, 2006
Read more
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now